Chemours Company (CC) is set for another landmark as it hit the volume of 1.48 million

Chemours Company (NYSE: CC) started the day on Wednesday, with a price increase of 4.02% at $28.73, before settling in for the price of $27.62 at the close. Taking a more long-term approach, CC posted a 52-week range of $15.10-$39.05.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Basic Materials Sector giants’ yearly sales growth during the last 5-year period was -0.67%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.58%. This publicly-traded company’s shares outstanding now amounts to $148.59 million, simultaneously with a float of $147.05 million. The organization now has a market capitalization sitting at $4.28 billion. At the time of writing, stock’s 50-day Moving Average stood at $27.97, while the 200-day Moving Average is $30.21.

Chemours Company (CC) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Specialty Chemicals Industry. Chemours Company’s current insider ownership accounts for 1.18%, in contrast to 76.76% institutional ownership. According to the most recent insider trade that took place on Jun 09 ’23, this organization’s President and CEO bought 7,661 shares at the rate of 34.63, making the entire transaction reach 265,300 in total value, affecting insider ownership by 266,955. Preceding that transaction, on Jun 09 ’23, Company’s SVP Corp Communications & CBO sold 5,125 for 32.30, making the whole transaction’s value amount to 165,537. This particular insider is now the holder of 13,890 in total.

Chemours Company (CC) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 12/30/2023, the organization reported $0.31 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $0.25) by $0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.97 per share during the current fiscal year.

Chemours Company’s EPS increase for this current 12-month fiscal period is 3.58% and is forecasted to reach 4.26 in the upcoming year.

Chemours Company (NYSE: CC) Trading Performance Indicators

Let’s observe the current performance indicators for Chemours Company (CC). It’s Quick Ratio in the last reported quarter now stands at 1.00. The Stock has managed to achieve an average true range (ATR) of 1.63. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.71. Similarly, its price to free cash flow for trailing twelve months is now 22.98.

In the same vein, CC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.60, a figure that is expected to reach 0.36 in the next quarter, and analysts are predicting that it will be 4.26 at the market close of one year from today.

Technical Analysis of Chemours Company (CC)

If we take a close look at the recent performances of Chemours Company (NYSE: CC), its last 5-days Average volume was 3.12 million that shows progress from its year to date volume of 2.05 million. During the previous 9 days, stock’s Stochastic %D was recorded 88.48% While, its Average True Range was 1.70.

Raw Stochastic average of Chemours Company (CC) in the period of the previous 100 days is set at 77.44%, which indicates a major fall in contrast to 96.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 68.50% that was lower than 81.44% volatility it exhibited in the past 100-days period.